Position in OABI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,418
-$498 QoQ
Shares Held
18,000
-9.5% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#109
of 141 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OABI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Saba Capital Management, L.P. holds $534,576 across 8 Biotechnology names. OABI ranks #2 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNA |
Atrium Therapeutics, Inc.
|
39,640 | $533,158 | |
| 2 | OABI |
OmniAb, Inc.
This page
|
18,000 | $1,418 | |
| 3 | OSRH |
OSR Health, Inc.
|
250,000 | $0 | |
| 4 | ASBP |
Aspire Biopharma Holdings, Inc.
|
983,603 | $0 | |
| 5 | PBM |
Psyence Biomedical Ltd.
|
297,847 | $0 | |
| 6 | CDIO |
Cardio Diagnostics Holdings, Inc.
|
199,839 | $0 | |
| 7 | LIMN |
Liminatus Pharma, Inc.
|
233,761 | $0 | |
| 8 | CDT |
CDT Equity Inc.
|
765,000 | $0 |
All Filings in OABI
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,418 | 18,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,916 | 19,900 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,165 | 19,900 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,861 | 19,900 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,462 | 20,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,445 | 20,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,800 | 20,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,175 | 20,000 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||